A detailed history of Armis Advisers, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Armis Advisers, LLC holds 11,943 shares of ABT stock, worth $1.55 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
11,943
Previous 10,612 12.54%
Holding current value
$1.55 Million
Previous $1.41 Billion 6.26%
% of portfolio
0.14%
Previous 0.11%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$120.51 - $136.62 $160,398 - $181,841
1,331 Added 12.54%
11,943 $1.49 Billion
Q2 2025

Jul 15, 2025

BUY
$123.95 - $138.08 $310,246 - $345,614
2,503 Added 30.87%
10,612 $1.41 Billion
Q1 2025

May 08, 2025

BUY
$111.1 - $140.22 $702,929 - $887,171
6,327 Added 355.05%
8,109 $1.06 Billion
Q4 2024

Feb 25, 2025

BUY
$111.93 - $119.39 $199,459 - $212,752
1,782 New
1,782 $202 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Armis Advisers, LLC Portfolio

Follow Armis Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armis Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armis Advisers, LLC with notifications on news.